The Differential Effects of a Selective Kappa-Opioid Receptor Agonist, U50488, in Guinea Pig Heart Tissues

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/bmri/volume-2015/906039/figures/906039.fig.003a.svgz" name="906039.fig.003a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>norBNI pretreatment</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/bmri/volume-2015/906039/figures/906039.fig.003b.svgz" name="906039.fig.003b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>PTX 150 <i>μ</i>g/kg, i.p.</td></tr></table>

<div>Representative tracings show the effect of norBNI and PTX on the effect of U50488 in left atria. (a) A norBNI (1 <i>μ</i>mol/L) pretreated atrium. (b) An atrium from PTX-pretreated guinea pig (150 <i>μ</i>g/kg for 24 h).</div>

BioMed Research International

fig3

Figure 3

Figure 3: The Differential Effects of a Selective Kappa-Opioid Receptor Agonist, U50488, in Guinea Pig Heart Tissues 